A phase I study of AB 101 (Insulin) in patients with type 2 diabetes mellitus
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2015
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 10 Dec 2015 According to a media release, AntriaBio will use the proceeds from a private placement transaction for phase I trials of AB101 in patients with type 1 and type 2 diabetes.
- 19 Nov 2015 New trial record
- 17 Nov 2015 According to an AntriaBio media release, company is planning to file an IND application with the U.S. FDA for AB101 and planning to initiate this and other trial (see profile 252952) in 2016.